Discover 212 paid clinical trials in Boise, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 212
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Boise ID, Meridian ID, Nampa ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase3, Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Boise ID, Meridian ID, Nampa ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Boise ID, Meridian ID, Nampa ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 60+
Code: NCT05976763
Phase3, Recruiting
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Boise ID, Meridian ID, Nampa ID, Caldwell ID,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Boise ID, Spokane WA, Yakima WA, Salt Lake City UT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase3, Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Boise ID, Meridian ID, Nampa ID, Fruitland ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05673148
Phase2, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Boise ID, Meridian ID, Nampa ID, Caldwell ID,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase3, Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Location: Boise ID, Meridian ID, Nampa ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04181060
Phase3, Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
for
Metastatic Malignant Neoplasm in the Liver,
Location: Boise ID, Meridian ID, Nampa ID, Fruitland ID,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05040360
Phase2, Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for
Malignant Female Reproductive System Neoplasm,
Location: Boise ID, Meridian ID, Nampa ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06126276
Phase2, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Boise ID, Spokane WA, Seattle WA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma